Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2023
|
| gptkbp:ATCCode |
gptkb:S01XA60
|
| gptkbp:chemicalClass |
RNA aptamer
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:IVERIC_bio
|
| gptkbp:genericName |
gptkb:avacincaptad_pegol
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zimura
|
| gptkbp:indication |
geographic atrophy secondary to age-related macular degeneration
|
| gptkbp:marketedAs |
gptkb:Astellas_Pharma
|
| gptkbp:mechanismOfAction |
complement C5 inhibitor
|
| gptkbp:regulates |
approved
|
| gptkbp:routeOfAdministration |
intravitreal injection
|
| gptkbp:bfsParent |
gptkb:Iveric_Bio
|
| gptkbp:bfsLayer |
6
|